Company intelligence / Profile preview

Bespoke Biotherapeutics

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Bespoke Biotherapeutics is a biotechnology company focused on developing next-generation, off-the-shelf cell therapies for cancer. The company leverages an induced pluripotent stem cell (iPSC) platform to engineer Natural Killer (NK) cells with enhanced persistence and anti-tumor activity. By utilizing a clonal master cell bank approach, Bespoke aims to provide scalable and standardized treatments that overcome the limitations of patient-specific CAR-T therapies. Their current pipeline targets hematological malignancies and is expanding into solid tumor indications.

Therapeutic areas: Oncology
Modalities: Cell therapyNK cell therapyInduced pluripotent stem cell derived therapy
Industry: Biotech

Beyond the preview

Go deeper on Bespoke Biotherapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bespoke Biotherapeutics.

Explore the full profile